Previous Close | 3.28 |
1-Year Change | -55.74% |
6-Months Change | -30.21% |
3-Months Change | -1.5% |
Moving Avg (50d) | 3.6581 |
Moving Avg (200d) | 8.0974 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 203.5M |
Beta (3-Years) | 1.43 |
Revenue Growth (ttm) | 30.26% |
Net Profit Margin (ttm) | 41.13% |
Return On Assets (ttm) | 14.65% |
EPS (ttm) | 0.8 |
PE Ratio (ttm) | 4.1 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |